baby intensive care

Sleep & Respiratory Newsletter

August 2018

In this issue

The economics of COPD therapy 2018


New study illustrates impact of HOT-HMV on hospital re-admission – and morbidity


Two of the four pillars of the Quadruple Aim of healthcare center explicitly on boosting patient outcomes and driving down costs. It is no secret that the two objectives are often intertwined. Healthier patient populations can translate to a less acute ―and expensive ―burden of care on society.


And therapies that promote better outcomes, and can be administered away from expensive brick-and-mortar acute care settings (i.e. the hospital), can be a win-win. A recent study1 suggests the combination of non-invasive ventilation (NIV) and home oxygen therapy (HOT) can do just that. 

Taking medication

Asthma and children

how to earn honors helping children with respiratory conditions ease into the new school year


Bring on the pencils, bring on the books... September’s yearly rite of passage is upon us. The return to school is full of promise – and maybe some dread – in the minds and hearts of children across the land. Dr. Lee-Chong Teofilo, Chief Medical Liaison at Philips, takes a timely opportunity to reflect on how children with everyday conditions such as asthma face unique challenges – and what we as parents and care providers can do to help.

News and topics

Philips recognized for Best Sleep Monitoring Solution with Philips SmartSleep


Philips to attend the European Respiratory Society Annual Congress 2018

Paris, France

September 15-19

Abstracts to be presented

“Patients expectations for a new lightweight portable noninvasive ventilator for shortness of breath”


“Influence of the VitaBreath on Exercise Tolerancein patients with COPD”


“Patient attitudes towards non-invasive ventilator to relive breathlessness”

COPD insider

What is COPD insider?

COPD Insider

Register now for exclusive content for COPD professionals

Sleep & Respiratory Newsletter

SRC icon

Want to get more sleep and respiratory articles, news and information from Philips?

Tell us what you think

Explore the world of COPD insider

Is technology the answer to the rise of OSA?


A recent article in HME News2 profiles how technology is being embraced to help address the rising tide of sleep disorders.

Awareness of sleep disorders – and their adverse impact on the brain and heart – has grown significantly in recent years among patients and care providers. Increased numbers of physicians are taking an interest into the science of sleep, and its impact on overall health and wellness.


New therapies and connected technologies are hitting the market, and more patients are being prescribed CPAP therapy.   Read more about technology companies such as Philips are very much exploring how technology can play a role in areas such as CPAP compliance.

The Sleep & Respiratory Newsletter: now archived and available for you


Every other month, the Sleep & Respiratory e-newsletter from Philips bring it to you. The clinical research. The insights, tips and best practices. Thought leadership from industry luminaries. The latest innovations and trends in sleep and respiratory health, diagnosis and care. Now for the first time, all of this accumulated knowledge is available & together in one place.

Stay up to date with CME

CHEST(R) Journal

Access new sleep and respiratory continuing medical education on the CHEST® Journal website (CHEST links require login) in the CHEST® CME Resource Center

1G. J. Criner1, Q. Gu2, P. B. Murphy3, L. Fusfeld2, B. Brueggenjuergen4, T. Goss2, N. Hart5; Pulm & Crit Care Med, Temple Univ Hosp, Philadelphia, PA, United States, 2Article published in United Publication Inc. © 2018 United Publications Inc. ALL RIGHTS RESERVED. Accessed June 2018.

Contact information

* This field is mandatory


Contact details


Company details


You are about to visit a Philips global content page


You are about to visit a Philips global content page


Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.